|
Nov 9
|
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Nov 6
|
TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting
|
|
Aug 10
|
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 10
|
TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
|